fig2
Figure 2. Recent progress of Bypass activation in TKI-resistant RCC. Created in BioRender. Dong, Z. (2025) https://BioRender.com/px2fkfx. TKI: Tyrosine kinase inhibitor; RCC: renal cell carcinoma.
Cancer Drug Resistance
ISSN 2578-532X (Online)
Navigation
Navigation
Committee on Publication Ethics
https://members.publicationethics.org/members/cancer-drug-resistance
Portico
All published articles will preserved here permanently:
https://www.portico.org/publishers/oae/
